Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
FI: 4,09
Tipo: Article
Colaboración
Año: 2022
Autores
Macauda, A; Clay-Gilmour, A; Hielscher, T; Hildebrandt, MAT; Kruszewski, M; Orlowski, RZ; Kumar, SK; Ziv, E; Orciuolo, E; Brown, EE; Forsti, A; Waller, RG; Machiela, MJ; Chanock, SJ; Camp, NJ; Rymko, M; Rany, M; Cozen, W; Varkonyi, J; Piredda, C; Pelosini, M; Belachew, AA; Subocz, E; Hemminki, K; Rybicka-Ramos, M; Giles, GG; Milne, RL; Hofmann, JN; Zaucha, JM; Vangsted, AJ; Goldschmidt, H; Rajkumar, SV; Tomczak, W; Sainz, J; Butrym, A; Watek, M; Iskierka-Jazdzewska, E; Buda, G; Robinson, DP; Jurczyszyn, A; Dudzinski, M; Martinez-Lopez, J; Sinnwell, JP; Slager, SL; Jamroziak, K; Reis, RMV; Weinhold, N; Bhatti, P; Carvajal-Carmona, LG; Zawirska, D; Norman, AD; Mazur, G; Berndt, SI; Campa, D; Vachon, CM; Canzian, F
Revista
Título: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Cuartil
- Q3